Barriers and facilitators of adherence to TB treatment in patients on concomitant TB and HIV treatment: a qualitative study

Mekdes K Gebremariam, Gunnar A Bjune, Jan C Frich, Mekdes K Gebremariam, Gunnar A Bjune, Jan C Frich

Abstract

Background: Tuberculosis is a major public health problem in Ethiopia, and a high number of TB patients are co-infected with HIV. There is a need for more knowledge about factors influencing treatment adherence in co-infected patients on concomitant treatment. The aim of the present study is to explore patients' and health care professionals' views about barriers and facilitators to TB treatment adherence in TB/HIV co-infected patients on concomitant treatment for TB and HIV.

Methods: Qualitative study using in-depth interviews with 15 TB/HIV co-infected patients and 9 health professionals and focus group discussions with 14 co-infected patients.

Results: We found that interplay of factors is involved in the decision making about medication intake. Factors that influenced adherence to TB treatment positively were beliefs in the curability of TB, beliefs in the severity of TB in the presence of HIV infection and support from families and health professionals. Barriers to treatment adherence were experiencing side effects, pill burden, economic constraints, lack of food, stigma with lack of disclosure, and lack of adequate communication with health professionals.

Conclusion: Health professionals and policy makers should be aware of factors influencing TB treatment in TB/HIV co-infected patients on concomitant treatment for TB and HIV. Our results suggest that provision of food and minimal financial support might facilitate adherence. Counseling might also facilitate adherence, in particular for those who start ART in the early phases of TB treatment, and beliefs related to side-effects and pill burden should be addressed. Information to the public may reduce TB and HIV related stigma.

References

    1. World Health Organization. Global Tuberculosis Control: surveillance, planning, financing. Geneva: World Health Organization; 2008.
    1. Federal Ministry of Health of Ethiopia. Manual for tuberculosis, leprosy and TB/HIV prevention and control program. Addis Ababa: Federal Ministry of Health; 2008.
    1. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in Sub-Saharan Africa: opportunities, challenges and changes in the era of antiretroviral treatment. Lancet. 2006;367:926–937. doi: 10.1016/S0140-6736(06)68383-9.
    1. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navaratne L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL. Treatment of tuberculosis in HIV infected persons in the era of highly active antiretroviral therapy. AIDS. 2002;16:75–83. doi: 10.1097/00002030-200201040-00010.
    1. Kwara A, Flanigan TP, Carter EJ. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status. Int J Tuberc Lung Dis. 2005;9:248–257.
    1. Breen RA, Miller RF, Gorsuch T, Smith CJ, Schwenk A, Holmes W, Ballinger J, Swaden L, Johnson MA, Cropley I, Lipman MC. Adverse events and treatment interruption in tuberculosis patients with and without HIV co-infection. Thorax. 2006;6:791–794. doi: 10.1136/thx.2006.058867.
    1. Aaron L, Saadoun D, Calatroni I, Launay O, Mémain N, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O. Tuberculosis in HIV infected patients: a comprehensive review. Clin Microbiol Infect. 2004;10:388–398. doi: 10.1111/j.1469-0691.2004.00758.x.
    1. Ingersoll KS, Cohen J. The impact of medication regimen factors on adherence to chronic treatment: a review of literature. J Behav Med. 2008;31:213–224. doi: 10.1007/s10865-007-9147-y.
    1. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23:1296–1310. doi: 10.1016/S0149-2918(01)80109-0.
    1. Richter A, Anton SE, Koch P, Dennett SL. The impact of reducing dose frequency on health outcomes. Clin Ther. 2003;25:2307–2335. doi: 10.1016/S0149-2918(03)80222-9.
    1. Munro SA, Lewin SA, Smith HJ, Engel ME, Fretheim A, Volmink J. Patient adherence to tuberculosis treatment: a systematic review of qualitative research. PLoS Med. 2007;4:e238. doi: 10.1371/journal.pmed.0040238.
    1. Shargie EB, Lindtjørn B. Determinants of treatment adherence among smear positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med. 2007;4:e37. doi: 10.1371/journal.pmed.0040037.
    1. World Health Organization. Adherence to Long Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
    1. Farmer P. Social scientists and the new tuberculosis. Soc Sci Med. 1997;44:347–358. doi: 10.1016/S0277-9536(96)00143-8.
    1. Chesney MA, Morin M, Sherr L. Adherence to HIV combination therapy. Soc Sci Med. 2000;50:1599–1605. doi: 10.1016/S0277-9536(99)00468-2.
    1. Demissie M, Kebede D. Defaulting from tuberculosis treatment at the Addis Abeba Tuberculosis Centre and factors associated with it. Ethiop Med J. 1994;32:97–106.
    1. Getahun H, Aragaw D. Tuberculosis in rural northwest Ethiopia: community perspective. Ethiop Med J. 2001;39:283–291.
    1. Tekle B, Mariam DH, Ali A. Defaulting from DOTS and its determinants in three districts of Arsi Zone in Ethiopia. Int J Tuberc Lung Dis. 2002;6:573–579.
    1. Shargie EB, Lindtjørn B. Determinants of treatment adherence among smear positive pulmonary tuberculosis patients in Southern Ethiopia. PLoS Med. 2007;4:e37. doi: 10.1371/journal.pmed.0040037.
    1. Michael KW, Belachew T, Jira C. Tuberculosis defaulters from the "dots" regimen in Jimma zone, southwest Ethiopia. Ethiop Med J. 2004;42:247–253.
    1. Getahun H, Maher D. Contribution of "TB clubs" to tuberculosis control in a rural district in Ethiopia. Int J Tuberc Lung Dis. 2000;4:174–178.
    1. Demissie M, Getahun H, Lindtjorn B. Community tuberculosis care through "TB clubs" in rural north Ethiopia. Soc Sci Med. 2003;56:2009–2018. doi: 10.1016/S0277-9536(02)00182-X.
    1. Sagbakken M, Frich JC, Bjune G. Barriers and enablers in the management of tuberculosis treatment in Addis-Ababa, Ethiopia: a qualitative study. BMC Public Health. 2008;8:11. doi: 10.1186/1471-2458-8-11.
    1. Addis Ababa Health Bureau. Strategic plan of Addis-Ababa City Administration Health Bureau 2004-2007. Addis Ababa: Addis Ababa Health Bureau; 2007.
    1. Federal Ministry of Health, Federal HIV/AIDS Prevention and Control Office. Guidelines For implementation of the antiretroviral therapy programme in Ethiopia. Addis Ababa: Federal Ministry of Health; 2007.
    1. Cummings KM, Becker MH, Maile MC. Bringing the models together: an empirical approach to combining variables used to explain health actions. J Behav Med. 1980;3:123–145. doi: 10.1007/BF00844986.
    1. Noyes J, Popay J. Directly observed therapy and tuberculosis: how can a systematic review of qualitative research contribute to improving services? J Adv Nurs. 2007;57:227–243. doi: 10.1111/j.1365-2648.2006.04092.x.
    1. Malterud K. Shared understanding of the qualitative research process. Guidelines for the medical researcher. Fam Pract. 1993;10:201–206. doi: 10.1093/fampra/10.2.201.
    1. Liefooghe R, Baliddawa JB, Kipruto EM, Vermeire C, De Munynck AO. From their own perspective. A Kenyan community's perception of tuberculosis. Trop Med Int Health. 1997;2:809–821. doi: 10.1046/j.1365-3156.1997.d01-380.x.
    1. Rowe KA, Makhubele B, Hargreaves JR, Porter JD, Hausler HP, Pronyk PM. Adherence to TB preventive therapy for HIV-positive patients in rural South Africa: implications for antiretroviral delivery in resource-poor settings? Int J Tuberc Lung Dis. 2005;9:263–269.
    1. Edginton ME, Sekatane CS, Goldstein SJ. Patients' beliefs: do they affect tuberculosis control? A study in a rural district of South Africa. Int J Tuberc Lung Dis. 2002;6:1075–1082.
    1. Mehta S, Moore RD, Graham NM. Potential factors affecting adherence with HIV therapy. AIDS. 1997;11:1665–1670. doi: 10.1097/00002030-199714000-00002.
    1. Chesney M. Adherence to HAART regimens. AIDS Patient Care STDS. 2003;17:169–177. doi: 10.1089/108729103321619773.
    1. Rocha M, Pereira S, Ferreira L, Barros H. The role of adherence in tuberculosis HIV positive patients treated in ambulatory regimen. Eur Respir J. 2003;21:785–788. doi: 10.1183/09031936.03.00077302.
    1. Ngamvithayapong J, Uthaivoravit W, Yanai H, Akarasewi P, Sawanpanyalert P. Adherence to tuberculosis preventive therapy among HIV-infected persons in Chiang Rai Thailand. AIDS. 1997;11:107–112. doi: 10.1097/00002030-199701000-00016.
    1. Wares DF, Singh S, Acharya AK, Dangi R. Non-adherence to tuberculosis treatment in the eastern Tarai of Nepal. Int J Tuberc Lung Dis. 2003;7:327–335.
    1. Kaona FA, Tuba M, Siziva S, Sikaona L. An assessment of factors contributing to treatment adherence and knowledge of TB transmission among patients on TB treatment. BMC Public Health. 2004;4:68. doi: 10.1186/1471-2458-4-68.
    1. Hardon AP, Akurut D, Comoro C, Ekezie C, Irunde HF, Gerrits T, Kglatwane J, Kinsman J, Kwasa R, Maridadi J, Moroka TM, Moyo S, Nakiyemba A, Nsimba S, Ogenyi R, Oyabba T, Temu F, Laing R. Hunger, waiting time and transport costs: time to confront challenges to ART adherence in Africa. AIDS Care. 2007;19:658–665. doi: 10.1080/09540120701244943.
    1. Federal Ministry of Health, Federal HIV/AIDS Prevention and Control Office. Guidelines for Management of Opportunistic Infections and Antiretroviral Treatment in Adolescents and Adults in Ethiopia. Federal Ministry of Health; 2007.
    1. Corbett EL, Marston B, Churchyard GJ, De Cock KM. Tuberculosis in sub-Saharan Africa: opportunities, challenges, and change in the era of antiretroviral treatment. Lancet. 2006;367:926–937. doi: 10.1016/S0140-6736(06)68383-9.
    1. Ngamvithayapong J, Winkvist A, Diwan V. High AIDS awareness may cause tuberculosis patient delay: results from an HIV epidemic area, Thailand. AIDS. 2000;14:1413–1419. doi: 10.1097/00002030-200007070-00015.
    1. Daniel OJ, Alausa OK. Treatment outcome of TB/HIV positive and TB/HIV negative patients on directly observed treatment, short course (DOTS) in Sagamu, Nigeria. Niger J Med. 2006;15:222–226.
    1. Volmink J, Garner P. Directly observed therapy for treating tuberculosis. Cochrane Database Syst Rev. 2007. p. CD003343.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir